These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35780008)

  • 21. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Discovery Study Aimed at a Functional Cure for HBV.
    Watanabe T; Hayashi S; Tanaka Y
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rational selection of virologic and immunological biomarkers and therapeutic endpoints in the clinical trials of new drugs treating chronic hepatitis B].
    Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Apr; 30(4):429-438. PubMed ID: 35545570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B cure: From discovery to regulatory approval.
    Lok AS; Zoulim F; Dusheiko G; Ghany MG
    J Hepatol; 2017 Oct; 67(4):847-861. PubMed ID: 28778687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
    Revill P; Locarnini S
    Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the study of hepatitis B virus covalently closed circular DNA.
    Ji M; Hu K
    Virol Sin; 2017 Dec; 32(6):454-464. PubMed ID: 29280054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
    Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
    J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
    Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
    J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
    Qu B; Nebioglu F; Leuthold MM; Ni Y; Mutz P; Beneke J; Erfle H; Vondran FWR; Bartenschlager R; Urban S
    JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
    Singh P; Kairuz D; Arbuthnot P; Bloom K
    World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B core protein as a therapeutic target.
    Mak LY; Wong DK; Seto WK; Lai CL; Yuen MF
    Expert Opin Ther Targets; 2017 Dec; 21(12):1153-1159. PubMed ID: 29065733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
    Wooddell CI; Yuen MF; Chan HL; Gish RG; Locarnini SA; Chavez D; Ferrari C; Given BD; Hamilton J; Kanner SB; Lai CL; Lau JYN; Schluep T; Xu Z; Lanford RE; Lewis DL
    Sci Transl Med; 2017 Sep; 9(409):. PubMed ID: 28954926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection.
    Wu S; Yi W; Gao Y; Deng W; Bi X; Lin Y; Yang L; Lu Y; Liu R; Chang M; Shen G; Hu L; Zhang L; Li M; Xie Y
    Front Immunol; 2022; 13():893512. PubMed ID: 35634301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
    Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs in Development for Hepatitis B.
    Dawood A; Abdul Basit S; Jayaraj M; Gish RG
    Drugs; 2017 Aug; 77(12):1263-1280. PubMed ID: 28660478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
    Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.